A connected, multi-site on-body delivery platform for large-volume subcutaneous biologics.
Designed from the ground up to replace IV infusion as the default for high-dose therapy.

89%
of mAb oncology patients choose SC over IV when offered the option
>900
SC-formulated molecules currently in clinical development
300M→600M
SC administrations projected to double in five years

The System

From preparation to delivery to monitoring, ORBIS redefines patients' and caregivers' experience.

ORBIS covers the full administration workflow in three integrated stages.

01
Preparation
An automated filling station loads drug from multiple vials simultaneously, supporting single or multi-drug sessions. Integrated temperature management brings each unit to the target temperature before wear begins, without manual handling by the patient or caregiver.
Multi-vial fill Automated prep Temp management
02
Delivery
Multiple on-body injectors deploy across separate body sites in a single session. Each injector runs its own programmable infusion profile, with rate, timing, and sequencing set independently. Multi-drug co-administration is supported through separate, simultaneously active units.
Multi-site Multi-therapy Adjustable profiles
03
Monitoring
A central controller tracks delivery status across all active injectors in real time. Session data, including dose volume, duration, and any interruptions, is logged automatically and made available for HCP reporting, adherence tracking, and remote therapy support.
Real-time visibility Adherence logging HCP reporting

Interested in ORBIS as a combination-product partner or investor?

ORBIS is in active development. We are engaging with pharma development and investment partners focused on LVSC delivery and combination-product licensing.